Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.

International journal of oncology - 1 Jan 2002

Dahse Regine, Utting Michael, Werner Wolfram, Schimmel Bettina, Claussen Uwe, Junker Kerstin

Abstract excerpt

Molecular markers are needed for better distinguishing of non-invasive papillary (pTa) and minimally invasive (pT1) bladder carcinomas and for identifying individual tumors with a high risk of recurrence or disease progression. First aim of our study was to evaluate TP53 microsatellite and mutation analysis as an effective concept for the characterization of superficial bladder tumors with different biological...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Transitional Cell
Share to Chromosomes, Human, Pair 17

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Genes, p53

Share to Loss of Heterozygosity

Share to Microsatellite Repeats

Share to Neoplasm Staging

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 11743649

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.PMID 11743649Read ↗

Prognostic implications of p53 gene mutations in bladder tumors.Semantic proximity Read ↗

Identification of p53 gene mutations in bladder cancers and urine samples.Semantic proximity Read ↗

Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer.Semantic proximity Read ↗

P53 mutations in urinary bladder cancer patients from Central Poland.Semantic proximity Read ↗

p53 gene mutation in recurrent superficial bladder cancer.Semantic proximity Read ↗

TP53 gene mutations as an independent marker for urinary bladder cancer progression.Semantic proximity Read ↗

Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.Semantic proximity Read ↗

Microsatellite alterations at chromosomes 9p, 13q, and 17p in nonmuscle-invasive transitional cell carcinomas of the urinary bladder.Semantic proximity Read ↗

Molecular profiling of bladder tumors based on the detection of FGFR3 and TP53 mutations.Semantic proximity Read ↗

p53 mutations in urinary bladder cancerSemantic proximity Read ↗

Progression in transitional cell carcinoma of the urinary bladder--analysis of Tp53 gene mutations by temperature gradients and sequence in tumor tissues and in cellular urine sediments.Semantic proximity Read ↗

Allelic imbalance analysis using a single-nucleotide polymorphism microarray for the detection of bladder cancer recurrence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.